Stages of hemostasis
Vascular spasm
-transient effect
Platelet adhesion (general)
Platelet adesion steps
von Willebran factor
Platlet Aggregation
Lab tests for platelet plug formation
Extrinsic Clotting Pathway
1e. Tissue injury—>release tissue factor (factor III)
2e. Tissue factor III: Factor ViII—>VIIa
3e. Factors III & VIIa & Ca2+ (IV): X—>Xa
Intrinsic Pathway
1i. Rough endothelial surface and exposure of collagen: XII–>XIIa
2i. XIIa: XI—>XIa; (also activates kallikrein for what its worth)
3i. XIa: IX—>IXa
4i. Thrombin (IIa): VIII—>VIIIa
5i. IXa, VIIIa, platelet phospholipids and Ca2+: X–>Xa
Common Pathway
1c. Thrombin (IIa): V–>Va
2c. Xa and Va and Ca2 form prothrombinase complex
3c. Prothrombinase complex: II–>IIa (prothrombin to thrombin)
4c. Thrombin (Ca2+): Fibrinogen (I)—>Fibrin (Ia) (soft clot as monomers aggregate linked by H-bonds)
5c. Thrombin (Ca2+): XIII—->XIIIa
6c. XIIIa: Crosslinks fibrin monomners (hard clot)
XIIIa
- highly specific transglutaminase
Actions of thrombin
Extrinic pathway uses;
III, VII (injury)
Intrinsic pathway uses:
XII, XI, IX, VII (pathological processeses like atherosclerosis)
Components of prothrombinase comples
Xa, Va, Phospholipid, Ca2+
Components reqiring phospholipids
prothombinase complex, intrinsic tenase complex
Test for extrinsic coagulation pathway defect:
Test for intrinsic coagulation pathway defect:
Increased APTT (partial thromboblastin time)
γ-Carboxylase
Warfarin
Inhibits epoxide reductase in liver, necessary for the regeneration of the active form of Vitamin K
(inhibits γ-Carboxylase, preventing production of mature Prothrombin (Factor II), VII, IX, X and Proteins C, S, and Z (but those are more anticoagulants))
Fibrinolysis
Inactive plasminogen incorporated into developing clot
Contorl of hemostasis
Antithrombin III
Heparin
Activates antithrombin III (bind and inhibits factor Xa and IIa (thrombin))